Compared to Estimates, Dolby Laboratories (DLB) Q3 Earnings: A Look at Key Metrics

01.08.25 00:30 Uhr

Werte in diesem Artikel

Dolby Laboratories (DLB) reported $315.55 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 9.3%. EPS of $0.78 for the same period compares to $0.71 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $303.67 million, representing a surprise of +3.91%. The company delivered an EPS surprise of +8.33%, with the consensus EPS estimate being $0.72.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Licensing: $289.91 million versus $281.01 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +8.6% change.Revenue- Products and services: $25.64 million versus the three-analyst average estimate of $22.66 million. The reported number represents a year-over-year change of +18%.Revenue- Licensing- Market- PC: $33.59 million versus the two-analyst average estimate of $28.41 million. The reported number represents a year-over-year change of +21.7%.Revenue- Licensing- Market- Other: $60.66 million compared to the $65.55 million average estimate based on two analysts. The reported number represents a change of +15.3% year over year.Revenue- Licensing- Market- CE: $28.07 million versus the two-analyst average estimate of $30.03 million. The reported number represents a year-over-year change of -1%.Revenue- Licensing- Market- Broadcast: $111.29 million versus $100.27 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16.6% change.Revenue- Licensing- Market- Mobile: $56.3 million versus the two-analyst average estimate of $60.99 million. The reported number represents a year-over-year change of -10.8%.Gross Margin- Licensing: $268.19 million compared to the $263.61 million average estimate based on two analysts.Gross margin- Products and services: $3.35 million versus the two-analyst average estimate of $1.11 million.View all Key Company Metrics for Dolby Laboratories here>>>Shares of Dolby Laboratories have returned -0.4% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dolby Laboratories (DLB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Dolby Laboratories und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Dolby Laboratories

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Dolby Laboratories

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Dolby Laboratories Inc.

Wer­bung

Analysen zu Dolby Laboratories Inc.

DatumRatingAnalyst
02.08.2019Dolby Laboratories NeutralB. Riley FBR
25.10.2018Dolby Laboratories NeutralB. Riley FBR
05.09.2018Dolby Laboratories BuyR. F. Lafferty
26.07.2018Dolby Laboratories NeutralB. Riley FBR
16.01.2018Dolby Laboratories NeutralB. Riley FBR, Inc.
DatumRatingAnalyst
05.09.2018Dolby Laboratories BuyR. F. Lafferty
28.04.2016Dolby Laboratories BuyDougherty & Company LLC
25.04.2016Dolby Laboratories BuyDougherty & Company LLC
28.03.2016Dolby Laboratories BuyDougherty & Company LLC
28.01.2016Dolby Laboratories BuyDougherty & Company LLC
DatumRatingAnalyst
02.08.2019Dolby Laboratories NeutralB. Riley FBR
25.10.2018Dolby Laboratories NeutralB. Riley FBR
26.07.2018Dolby Laboratories NeutralB. Riley FBR
16.01.2018Dolby Laboratories NeutralB. Riley FBR, Inc.
22.01.2015Dolby Laboratories NeutralB. Riley & Co., LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dolby Laboratories Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen